Non-invasive imaging of lactate is of enormous significance, particularly in oncologic diseases or metabolic disorders. In this work, we applied Lactate-weighted Chemical Exchange Saturation Transfer (Lactate-CEST) magnetic resonance imaging (MRI) at 7 Tesla (7T) to newly-diagnosed glioma patients. Lactate-CEST MRI revealed increased levels of lactate production in brain tumors of patients with glioma and could therefore serve as an additional imaging biomarker in diagnostic oncology with implications for biopsy targeting, patient therapy and response monitoring.
This abstract and the presentation materials are available to members only; a login is required.